Precision degrader-antibody conjugates (pDACs) with a SMARCA2/4 dual payload as targeted therapeutics for acute myeloid leukemia 

Ryan Holmes, Andrew Moore, Max Foroutan, Jake Karwoski, Alex Grego, Carly Bachner1 Neha Bhagawat, Corey Basch, Soham Maity, Chun Chen, Sarah B. Pawley, Vijay Devannah, Sina Rezazadeh, Ross Kuskovsky, Joseph Rager, Kenneth Ray, Kirsten Gallagher, Yue Zou, Koichi Ito, Diane Heiser, Sang Hyun Lee, Peggy Scherle , Andrew P. Combs, Andrew W. Buesking